Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Lulu DAI"'
Autor:
Lulu Dai, Lin Tao, Dengqing Liao, Shimin Xiong, Yijun Liu, Nian Wu, Songlin An, Xubo Shen, Yuanzhong Zhou
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study investigated the effect of household air pollution on pregnant women with GDM, and assessed the modifying effect of a healthy lifestyle on this relationship. Household solid fuel exposure was defined as using solid fuels (coal, cr
Externí odkaz:
https://doaj.org/article/4e15feb5dc23434fb106cc6b46602848
Autor:
Jidong Liu, Huihui Tian, Xinchen Jin, Yanxiang Wang, Zhenhong Zhang, Mengxue Li, Lulu Dai, Xiaoli Zhang, Ling Jiang
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background 11β-hydroxylase deficiency (11β-OHD), caused by homozygosity or compound heterozygosity CYP11B1 variants, is the second most common cause of congenital adrenal hyperplasia (CAH). Due to the high degree of sequence identity betwe
Externí odkaz:
https://doaj.org/article/181d36ce8cd346c38ad49fe735fa276f
Autor:
Qifu Hong, Tao Pu, Maojie Li, Zhongbao Chen, Xingyan Liu, Rong Zeng, Mingzhe Zhang, Lulu Dai, Songlin An, Xubo Shen, Xuejun Shang, Yuanzhong Zhou, Kunming Tian
Publikováno v:
Environmental Sciences Europe, Vol 36, Iss 1, Pp 1-11 (2024)
Abstract Evidence about associations of phthalates metabolites with increased serum uric acid (SUA) levels in pregnant women remains unknown. To address this, we conducted a cross-sectional population-based study including 851 pregnant women from Zun
Externí odkaz:
https://doaj.org/article/34fbf546988d43f0b6b1b2b5b4443e20
Publikováno v:
International Journal of Pharmaceutics: X, Vol 8, Iss , Pp 100300- (2024)
Acute rejection (AR) remains a pivotal complication and leading cause of mortality within the first year following heart transplantation (HT). In this study, we assessed the impact of ultrasound-targeted microbubbles loaded with sirolimus (SIR-MBs) o
Externí odkaz:
https://doaj.org/article/36bd380e28ea4ae2b691c06078923247
Autor:
Luying Chen, Lulu Dai, Jiawei Xu, Lian Duan, Xiaoxia Hou, Lu Zhang, Libo Song, Fangfang Zhao, Yuerong Jiang
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307074 (2024)
IntroductionDespite the available secondary preventive treatments, the management of stable coronary artery disease (SCAD) remains challenging. Intermediate coronary lesion (ICL), defined as luminal stenosis between 50% and 70%, is a key stage of SCA
Externí odkaz:
https://doaj.org/article/c14f873cff7440d1a570410df3900f76
Publikováno v:
Chinese Journal of Lung Cancer, Vol 25, Iss 9, Pp 671-677 (2022)
In recent years, immune checkpoint inhibitors (ICIs) have greatly improved the survival rate of non-small cell lung cancer (NSCLC) patients without driver mutation. Compared with wild-type tumors, tumors with epidermal growth factor receptor (EGFR) m
Externí odkaz:
https://doaj.org/article/578e1d7c061d4d7a86ad2e94555398ac
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Heat Shock Proteins 70 (HSP70s) in insects act on a diverse range of substrates to assist with overcoming extreme high temperatures. MaltHSP70-2, a member of HSP70s, has been characterized to involve in the thermotolerance of Mono
Externí odkaz:
https://doaj.org/article/36a6e424fe9c4de5901ff3f30496a568
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Purpose: We aimed to evaluate the effects of Panax notoginseng preparations (PNP) containing Panax Notoginseng Saponins (PNS) or Panaxatriol Saponin (PTS) on platelet aggregation and coagulation in the adjuvant treatment of coronary heart disease (CH
Externí odkaz:
https://doaj.org/article/2381fe2676f2410e8a4e335745a73a40
Publikováno v:
Journal of Chromatography Open, Vol 2, Iss , Pp 100036- (2022)
Pinacol boronates are widely used in the pharmaceutical and biomedical industries as primary building blocks for many chemical reactions, such as Suzuki coupling. However, pinacol boronate esters are often susceptible to hydrolysis and degrade into c
Externí odkaz:
https://doaj.org/article/ed5201edd8b94946aaf44f361f973427
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 8, Pp 591-597 (2021)
In the past 20 years, with the development of molecular biology, the treatment of non-small cell lung cancer (NSCLC) has been developing. Targeted therapy has improved the survival period of patients with positive mutation of tumor driver gene. More
Externí odkaz:
https://doaj.org/article/7595933129764f77bf6010f43594bd64